Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life (Q102075576)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

title

Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Lan Ye

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Holger Cynis

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Paul H. Weinreb

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Thierry Bussiere

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Lary C. Walker

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Mathias Jucker

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

author name string

Ruth E Uhlmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Christine Rother

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Jay Rasmussen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Juliane Schelle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Carina Bergmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Emily M Ullrich Gavilanes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Anika Buehler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Frank Baumann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Angelos Skodras

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Rawaa Al-Shaana

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Natalie Beschorner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Stephan A Kaeser

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Ulrike Obermüller

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Søren Christensen

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Fredrik Kartberg

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Jeffrey B Stavenhagen

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Jens-Ulrich Rahfeld

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Fang Qian

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

Matthias Staufenbiel

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

publication date

16 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

18 November 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Stop Alzheimer's before it starts.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Estimation of amyloid distribution by [F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Memory decline accompanies subthreshold amyloid accumulation.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Multisite study of the relationships between antemortem [C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Persistence of Aβ seeds in APP null mouse brain.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

The amyloid state of proteins in human diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Aβ oligomers trigger and accelerate Aβ seeding

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Cerebral hemorrhage after passive anti-Abeta immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathology

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

On the lag phase in amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

The evolution of preclinical Alzheimer's disease: implications for prevention trials

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Amyloid precursor protein truncated at any of the gamma-secretase sites is not cleaved to beta-amyloid

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Early Aβ reduction prevents progression of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Analysis of amyloid aggregates using agarose gel electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1038%2FS41593-020-00737-W

7 January 2021

10.1038/S41593-020-00737-W

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33199898%20AND%20SRC:MED&resulttype=core&format=json

18 November 2020

1 reference